Bariatric surgery for type 2 diabetes (Q34280152)

1 August 2017

title

Bariatric surgery for type 2 diabetes (English)

1 reference

1 August 2017

0 references

0 references

Paul Zimmet

4

0 references

Carel le Roux

object named as

Carel W le Roux

series ordinal

2

0 references

John B Dixon

series ordinal

1

object named as

John B Dixon

1 reference

1 August 2017

Francesco Rubino

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

9 June 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

379

1 reference

1 August 2017

issue

9833

1 reference

1 August 2017

page(s)

2300-2311

1 reference

The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Ten putative contributors to the obesity epidemic

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Developmental and epigenetic pathways to obesity: an evolutionary-developmental perspective.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Increasing BMI and waist circumference and prevalence of obesity among adults with Type 2 diabetes: the National Health and Nutrition Examination Surveys

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Global estimates of the prevalence of diabetes for 2010 and 2030

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Evaluation of risk factors for development of complications in Type II diabetes in Europe

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Should surgeons treat diabetes in severely obese people?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Bariatric surgery: an IDF statement for obese Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

IDF's view of bariatric surgery in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Bariatric surgery: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Depression in association with severe obesity: changes with weight loss

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Long-term mortality after gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Cancer and obesity: effect of bariatric surgery

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Financial implications of coverage for laparoscopic adjustable gastric banding

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Canadian Physicians' Use of Antiobesity Drugs and Their Referral Patterns to Weight Management Programs or Providers: The SOCCER Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Perceived barriers to bariatric surgery among morbidly obese patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Metabolic/bariatric surgery Worldwide 2008.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Bariatric surgery worldwide 2003.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Systematic review of sleeve gastrectomy as staging and primary bariatric procedure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Systematic review of medium-term weight loss after bariatric operations

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Perioperative safety in the longitudinal assessment of bariatric surgery

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Trends in mortality in bariatric surgery: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Laparoscopic adjustable gastric banding in 1,791 consecutive obese patients: 12-year results.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Substantial intentional weight loss and mortality in the severely obese

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Baria

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Management of obesity: summary of SIGN guideline

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Inter-disciplinary European guidelines on surgery of severe obesity

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Beyond the BMI: the search for better guidelines for bariatric surgery

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Narrative review: effect of bariatric surgery on type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

1 reference

7 January 2021

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Efficacy of the Roux-en-Y Gastric Bypass Compared to Medically Managed Controls in Meeting the American Diabetes Association Composite End Point Goals for Management of Type 2 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Impact of laparoscopic adjustable gastric banding on type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

How do we define cure of diabetes?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Bariatric surgery: mechanisms, indications and outcomes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Energy intake in weight-reduced humans

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Long-Term Persistence of Hormonal Adaptations to Weight Loss

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

The Role of β-Cell Function and Insulin Sensitivity in the Remission of Type 2 Diabetes after Gastric Bypass Surgery

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Gastric bypass reduces fat intake and preference.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Bariatric surgery: unstressing or boosting the beta-cell?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

The effect of laparoscopic adjustable gastric bands on esophageal motility and the gastroesophageal junction: analysis using high-resolution video manometry

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Hunger control and regular physical activity facilitate weight loss after laparoscopic adjustable gastric banding

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Changes in eating behaviour and meal pattern following Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Is the Roux limb a determinant for meal size after gastric bypass surgery?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Magnitude and variability of the glucagon-like peptide-1 response in patients with type 2 diabetes up to 2 years following gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Gastric bypass increases energy expenditure in rats

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Roux-en-Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese rats

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

beta-cell failure in diabetes and preservation by clinical treatment

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Post-bypass hypoglycaemia: A review of current findings

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Sweet eating is not a predictor of outcome after Lap-Band placement. Can we finally bury the myth?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

The use of low-glycaemic index diets in diabetes control

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Patient management after LAP-BAND placement

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Alterations of sucrose preference after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Linking gustatory neurobiology to behavior in vertebrates

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Has laparoscopic bariatric surgery been accepted in Japan? The experience of a single surgeon

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Thirty‐Day Morbidity and Mortality of the Laparoscopic Ileal Interposition Associated with Sleeve Gastrectomy for the Treatment of Type 2 Diabetic Patients with BMI <35: An Analysis of 454 Consecutive Patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Surgical treatment of morbid obesity: mid-term outcomes of the laparoscopic ileal interposition associated to a sleeve gastrectomy in 120 patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Evidence-based review of the Bioenterics intragastric balloon for weight loss

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Long-term follow-up of gastric stimulation for obesity: the Mestre 8-year experience

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)60401-2

7 January 2021

10.1016/S0140-6736(12)60401-2

Identifiers

DOI

1 reference

1 August 2017

1 reference